Facebook
Twitter
Telegram
Report an ErrorAziyo Biologics Financial Statements 2011-2024 | AZYO
Annual Financial Statements Aziyo Biologics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
26.9 M | 56.7 M | 65.8 M | 165 M | - | - | - | - | - | - | - | - | - |
Shares |
18.2 M | 13.8 M | 10.4 M | 10.2 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
1.48 | 4.1 | 6.3 | 13.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-37.7 M | -32.9 M | -24.8 M | -21.8 M | -11.9 M | -11.6 M | - | - | - | - | - | - | - |
Revenue |
24.7 M | 23.8 M | 47.4 M | 42.7 M | 42.9 M | 39 M | - | - | - | - | - | - | - |
Cost of Revenue |
13.7 M | 12.2 M | 28.4 M | 22.1 M | 23.1 M | - | - | - | - | - | - | - | - |
Gross Profit |
11.1 M | 11.6 M | 19 M | 20.6 M | 19.8 M | 15.9 M | - | - | - | - | - | - | - |
Operating Income |
-30.5 M | -35.2 M | -23 M | -13.6 M | -8.41 M | - | - | - | - | - | - | - | - |
Interest Expense |
5.8 M | 5.12 M | 5.32 M | 5.63 M | 5.38 M | - | - | - | - | - | - | - | - |
EBITDA |
-26.8 M | -31.5 M | -19.3 M | -9.74 M | -4.55 M | -4.4 M | - | - | - | - | - | - | - |
Operating Expenses |
41.6 M | 46.8 M | 42.1 M | 34.2 M | 28.2 M | 24.2 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
14.1 M | 16.1 M | 13.7 M | 13.2 M | 9.62 M | 8.52 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Aziyo Biologics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
17 M | 16.2 M | 16.1 M | - | 13.7 M | 13.6 M | 13.6 M | - | 10.2 M | 10.2 M | 10.2 M | - | 648 K | 648 K | 648 K | 648 K | 645 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-9.75 M | -10.6 M | -7.97 M | - | -9.91 M | -9.4 M | -8.15 M | - | -8.32 M | -2.38 M | -5.07 M | - | -6.73 M | -5.18 M | -4.56 M | - | -3.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
6.13 M | 10.3 M | 13 M | - | 5.85 M | 12.6 M | 11.5 M | - | 11.5 M | 12.2 M | 12.9 M | - | 11.8 M | 8.58 M | 9.86 M | - | 11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
3.29 M | 9.32 M | 6.72 M | - | 2.91 M | 7.74 M | 7.21 M | - | 7.8 M | 6.55 M | 6.56 M | - | 6.23 M | 4.8 M | 4.65 M | - | 5.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
2.84 M | 980 K | 6.33 M | - | 2.94 M | 4.9 M | 4.28 M | - | 3.69 M | 5.61 M | 6.33 M | - | 5.54 M | 3.78 M | 5.22 M | - | 5.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-7.37 M | -9.08 M | -6.42 M | - | -8.97 M | -8.18 M | -6.92 M | - | -6.98 M | -4.6 M | -3.7 M | - | -2.69 M | -3.76 M | -3.18 M | - | -1.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.45 M | 1.52 M | 1.54 M | - | 1.25 M | 1.2 M | 1.22 M | - | 1.33 M | 1.35 M | 1.36 M | - | 1.46 M | 1.41 M | 1.37 M | - | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.52 M | -8.24 M | -5.47 M | - | -8.12 M | -7.33 M | -5.99 M | - | -4.18 M | -2.73 M | -2.77 M | - | 230 K | -1.81 M | -2.21 M | - | 1.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
10.2 M | 10.1 M | 12.7 M | - | 11.9 M | 13.1 M | 11.2 M | - | 10.7 M | 10.2 M | 10 M | - | 8.23 M | 7.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.76 M | 4 M | 3.68 M | - | 4.33 M | 4.71 M | 4.02 M | - | 3.52 M | 3.53 M | 3.6 M | - | 2.67 M | 2.08 M | 2.61 M | - | 2.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency